nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00304	0.00341	CcSEcCtD
Tramadol—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00301	0.00338	CcSEcCtD
Tramadol—Viral infection—Lisinopril—dilated cardiomyopathy	0.003	0.00336	CcSEcCtD
Tramadol—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00298	0.00335	CcSEcCtD
Tramadol—Polyuria—Furosemide—dilated cardiomyopathy	0.00298	0.00335	CcSEcCtD
Tramadol—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00298	0.00334	CcSEcCtD
Tramadol—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00298	0.00334	CcSEcCtD
Tramadol—Cough increased—Lisinopril—dilated cardiomyopathy	0.00296	0.00332	CcSEcCtD
Tramadol—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00293	0.00329	CcSEcCtD
Tramadol—Deafness—Furosemide—dilated cardiomyopathy	0.00293	0.00329	CcSEcCtD
Tramadol—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00292	0.00327	CcSEcCtD
Tramadol—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0029	0.00326	CcSEcCtD
Tramadol—Gout—Lisinopril—dilated cardiomyopathy	0.0029	0.00325	CcSEcCtD
Tramadol—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00284	0.00319	CcSEcCtD
Tramadol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00279	0.00313	CcSEcCtD
Tramadol—Thirst—Furosemide—dilated cardiomyopathy	0.00275	0.00309	CcSEcCtD
Tramadol—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00274	0.00307	CcSEcCtD
Tramadol—Neck pain—Lisinopril—dilated cardiomyopathy	0.00274	0.00307	CcSEcCtD
Tramadol—Purpura—Furosemide—dilated cardiomyopathy	0.00272	0.00305	CcSEcCtD
Tramadol—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00271	0.00304	CcSEcCtD
Tramadol—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00269	0.00302	CcSEcCtD
Tramadol—Lethargy—Furosemide—dilated cardiomyopathy	0.00267	0.003	CcSEcCtD
Tramadol—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00266	0.00298	CcSEcCtD
Tramadol—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00265	0.00297	CcSEcCtD
Tramadol—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00263	0.00295	CcSEcCtD
Tramadol—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00263	0.00295	CcSEcCtD
Tramadol—Malaise—Spironolactone—dilated cardiomyopathy	0.00262	0.00293	CcSEcCtD
Tramadol—Cystitis—Lisinopril—dilated cardiomyopathy	0.00261	0.00293	CcSEcCtD
Tramadol—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00256	0.00287	CcSEcCtD
Tramadol—Irritability—Furosemide—dilated cardiomyopathy	0.0025	0.0028	CcSEcCtD
Tramadol—Urinary retention—Furosemide—dilated cardiomyopathy	0.00249	0.00279	CcSEcCtD
Tramadol—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00245	0.00275	CcSEcCtD
Tramadol—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00245	0.00275	CcSEcCtD
Tramadol—Discomfort—Spironolactone—dilated cardiomyopathy	0.00244	0.00274	CcSEcCtD
Tramadol—Dehydration—Furosemide—dilated cardiomyopathy	0.00244	0.00273	CcSEcCtD
Tramadol—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00241	0.0027	CcSEcCtD
Tramadol—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00239	0.00268	CcSEcCtD
Tramadol—Confusional state—Spironolactone—dilated cardiomyopathy	0.00239	0.00268	CcSEcCtD
Tramadol—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00238	0.00267	CcSEcCtD
Tramadol—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00237	0.00266	CcSEcCtD
Tramadol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00237	0.00265	CcSEcCtD
Tramadol—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00236	0.00265	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00236	0.00265	CcSEcCtD
Tramadol—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00232	0.0026	CcSEcCtD
Tramadol—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00231	0.00259	CcSEcCtD
Tramadol—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00228	0.00256	CcSEcCtD
Tramadol—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00227	0.00255	CcSEcCtD
Tramadol—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00226	0.00254	CcSEcCtD
Tramadol—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00224	0.00251	CcSEcCtD
Tramadol—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00222	0.00249	CcSEcCtD
Tramadol—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00222	0.00249	CcSEcCtD
Tramadol—Eczema—Lisinopril—dilated cardiomyopathy	0.00219	0.00245	CcSEcCtD
Tramadol—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00219	0.00245	CcSEcCtD
Tramadol—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00218	0.00244	CcSEcCtD
Tramadol—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00216	0.00242	CcSEcCtD
Tramadol—Injury—Lisinopril—dilated cardiomyopathy	0.00214	0.0024	CcSEcCtD
Tramadol—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00212	0.00238	CcSEcCtD
Tramadol—Somnolence—Spironolactone—dilated cardiomyopathy	0.0021	0.00236	CcSEcCtD
Tramadol—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00209	0.00235	CcSEcCtD
Tramadol—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00207	0.00233	CcSEcCtD
Tramadol—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00207	0.00232	CcSEcCtD
Tramadol—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00207	0.00232	CcSEcCtD
Tramadol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00204	0.00229	CcSEcCtD
Tramadol—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00204	0.00229	CcSEcCtD
Tramadol—Arthritis—Lisinopril—dilated cardiomyopathy	0.00202	0.00227	CcSEcCtD
Tramadol—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00201	0.00226	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.002	0.00225	CcSEcCtD
Tramadol—Renal failure—Furosemide—dilated cardiomyopathy	0.00198	0.00223	CcSEcCtD
Tramadol—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00197	0.00221	CcSEcCtD
Tramadol—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00197	0.00221	CcSEcCtD
Tramadol—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00197	0.00221	CcSEcCtD
Tramadol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00195	0.00219	CcSEcCtD
Tramadol—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00195	0.00219	CcSEcCtD
Tramadol—Sweating—Furosemide—dilated cardiomyopathy	0.00194	0.00217	CcSEcCtD
Tramadol—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00191	0.00214	CcSEcCtD
Tramadol—Urticaria—Spironolactone—dilated cardiomyopathy	0.00188	0.00211	CcSEcCtD
Tramadol—Irritability—Lisinopril—dilated cardiomyopathy	0.00188	0.0021	CcSEcCtD
Tramadol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00187	0.0021	CcSEcCtD
Tramadol—Ataxia—Lisinopril—dilated cardiomyopathy	0.00185	0.00207	CcSEcCtD
Tramadol—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00184	0.00207	CcSEcCtD
Tramadol—Dehydration—Lisinopril—dilated cardiomyopathy	0.00183	0.00205	CcSEcCtD
Tramadol—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.0018	0.00201	CcSEcCtD
Tramadol—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00179	0.00201	CcSEcCtD
Tramadol—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00178	0.00199	CcSEcCtD
Tramadol—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00178	0.00199	CcSEcCtD
Tramadol—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00177	0.00199	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00177	0.00199	CcSEcCtD
Tramadol—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00176	0.00197	CcSEcCtD
Tramadol—Visual impairment—Furosemide—dilated cardiomyopathy	0.00175	0.00196	CcSEcCtD
Tramadol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00174	0.00196	CcSEcCtD
Tramadol—Gastritis—Lisinopril—dilated cardiomyopathy	0.00174	0.00195	CcSEcCtD
Tramadol—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00171	0.00192	CcSEcCtD
Tramadol—Asthma—Lisinopril—dilated cardiomyopathy	0.0017	0.00191	CcSEcCtD
Tramadol—Influenza—Lisinopril—dilated cardiomyopathy	0.0017	0.00191	CcSEcCtD
Tramadol—Eye disorder—Furosemide—dilated cardiomyopathy	0.00169	0.0019	CcSEcCtD
Tramadol—Tinnitus—Furosemide—dilated cardiomyopathy	0.00169	0.0019	CcSEcCtD
Tramadol—Pruritus—Spironolactone—dilated cardiomyopathy	0.00167	0.00188	CcSEcCtD
Tramadol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00167	0.00187	CcSEcCtD
Tramadol—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00167	0.00187	CcSEcCtD
Tramadol—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00165	0.00186	CcSEcCtD
Tramadol—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00165	0.00186	CcSEcCtD
Tramadol—Angiopathy—Furosemide—dilated cardiomyopathy	0.00164	0.00184	CcSEcCtD
Tramadol—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00164	0.00184	CcSEcCtD
Tramadol—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00163	0.00183	CcSEcCtD
Tramadol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00162	0.00182	CcSEcCtD
Tramadol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00162	0.00182	CcSEcCtD
Tramadol—Dysuria—Lisinopril—dilated cardiomyopathy	0.00159	0.00178	CcSEcCtD
Tramadol—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00158	0.00177	CcSEcCtD
Tramadol—Erythema—Furosemide—dilated cardiomyopathy	0.00158	0.00177	CcSEcCtD
Tramadol—Malnutrition—Furosemide—dilated cardiomyopathy	0.00158	0.00177	CcSEcCtD
Tramadol—Dizziness—Spironolactone—dilated cardiomyopathy	0.00157	0.00176	CcSEcCtD
Tramadol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00156	0.00176	CcSEcCtD
Tramadol—Flatulence—Furosemide—dilated cardiomyopathy	0.00155	0.00174	CcSEcCtD
Tramadol—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00155	0.00174	CcSEcCtD
Tramadol—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00155	0.00173	CcSEcCtD
Tramadol—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00154	0.00172	CcSEcCtD
Tramadol—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00153	0.00172	CcSEcCtD
Tramadol—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00152	0.00171	CcSEcCtD
Tramadol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00152	0.0017	CcSEcCtD
Tramadol—Depression—Lisinopril—dilated cardiomyopathy	0.00151	0.00169	CcSEcCtD
Tramadol—Vomiting—Spironolactone—dilated cardiomyopathy	0.0015	0.00169	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.0015	0.00168	CcSEcCtD
Tramadol—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00149	0.00168	CcSEcCtD
Tramadol—Rash—Spironolactone—dilated cardiomyopathy	0.00149	0.00167	CcSEcCtD
Tramadol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00149	0.00167	CcSEcCtD
Tramadol—Renal failure—Lisinopril—dilated cardiomyopathy	0.00149	0.00167	CcSEcCtD
Tramadol—Vision blurred—Furosemide—dilated cardiomyopathy	0.00149	0.00167	CcSEcCtD
Tramadol—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00148	0.00167	CcSEcCtD
Tramadol—Headache—Spironolactone—dilated cardiomyopathy	0.00148	0.00166	CcSEcCtD
Tramadol—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00147	0.00165	CcSEcCtD
Tramadol—Anaemia—Furosemide—dilated cardiomyopathy	0.00146	0.00164	CcSEcCtD
Tramadol—Sweating—Lisinopril—dilated cardiomyopathy	0.00145	0.00163	CcSEcCtD
Tramadol—Agitation—Furosemide—dilated cardiomyopathy	0.00145	0.00163	CcSEcCtD
Tramadol—Haematuria—Lisinopril—dilated cardiomyopathy	0.00144	0.00162	CcSEcCtD
Tramadol—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00143	0.00161	CcSEcCtD
Tramadol—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00143	0.0016	CcSEcCtD
Tramadol—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00142	0.00159	CcSEcCtD
Tramadol—Vertigo—Furosemide—dilated cardiomyopathy	0.00142	0.00159	CcSEcCtD
Tramadol—Nausea—Spironolactone—dilated cardiomyopathy	0.00141	0.00158	CcSEcCtD
Tramadol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00138	0.00155	CcSEcCtD
Tramadol—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00136	0.00153	CcSEcCtD
Tramadol—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00136	0.00153	CcSEcCtD
Tramadol—Hallucination—Lisinopril—dilated cardiomyopathy	0.00135	0.00152	CcSEcCtD
Tramadol—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00135	0.00151	CcSEcCtD
Tramadol—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00134	0.00151	CcSEcCtD
Tramadol—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00134	0.0015	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00133	0.0015	CcSEcCtD
Tramadol—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00133	0.0015	CcSEcCtD
Tramadol—Dry mouth—Furosemide—dilated cardiomyopathy	0.00131	0.00147	CcSEcCtD
Tramadol—Confusional state—Furosemide—dilated cardiomyopathy	0.0013	0.00146	CcSEcCtD
Tramadol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00129	0.00144	CcSEcCtD
Tramadol—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00129	0.00144	CcSEcCtD
Tramadol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00127	0.00142	CcSEcCtD
Tramadol—Shock—Furosemide—dilated cardiomyopathy	0.00127	0.00142	CcSEcCtD
Tramadol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00126	0.00142	CcSEcCtD
Tramadol—Flushing—Lisinopril—dilated cardiomyopathy	0.00126	0.00142	CcSEcCtD
Tramadol—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00126	0.00141	CcSEcCtD
Tramadol—Skin disorder—Furosemide—dilated cardiomyopathy	0.00125	0.0014	CcSEcCtD
Tramadol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00124	0.0014	CcSEcCtD
Tramadol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00123	0.00138	CcSEcCtD
Tramadol—Anorexia—Furosemide—dilated cardiomyopathy	0.00123	0.00138	CcSEcCtD
Tramadol—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00123	0.00137	CcSEcCtD
Tramadol—Chills—Lisinopril—dilated cardiomyopathy	0.00122	0.00137	CcSEcCtD
Tramadol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00121	0.00136	CcSEcCtD
Tramadol—Hypotension—Furosemide—dilated cardiomyopathy	0.0012	0.00135	CcSEcCtD
Tramadol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00119	0.00134	CcSEcCtD
Tramadol—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00118	0.00133	CcSEcCtD
Tramadol—Erythema—Lisinopril—dilated cardiomyopathy	0.00118	0.00133	CcSEcCtD
Tramadol—Flatulence—Lisinopril—dilated cardiomyopathy	0.00117	0.00131	CcSEcCtD
Tramadol—Tension—Lisinopril—dilated cardiomyopathy	0.00116	0.0013	CcSEcCtD
Tramadol—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00116	0.0013	CcSEcCtD
Tramadol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00116	0.0013	CcSEcCtD
Tramadol—Nervousness—Lisinopril—dilated cardiomyopathy	0.00115	0.00129	CcSEcCtD
Tramadol—Back pain—Lisinopril—dilated cardiomyopathy	0.00115	0.00128	CcSEcCtD
Tramadol—Somnolence—Furosemide—dilated cardiomyopathy	0.00114	0.00128	CcSEcCtD
Tramadol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00114	0.00128	CcSEcCtD
Tramadol—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00112	0.00126	CcSEcCtD
Tramadol—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00112	0.00125	CcSEcCtD
Tramadol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00111	0.00125	CcSEcCtD
Tramadol—Fatigue—Furosemide—dilated cardiomyopathy	0.00111	0.00125	CcSEcCtD
Tramadol—Tremor—Lisinopril—dilated cardiomyopathy	0.00111	0.00124	CcSEcCtD
Tramadol—Constipation—Furosemide—dilated cardiomyopathy	0.0011	0.00124	CcSEcCtD
Tramadol—Pain—Furosemide—dilated cardiomyopathy	0.0011	0.00124	CcSEcCtD
Tramadol—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.0011	0.00123	CcSEcCtD
Tramadol—Anaemia—Lisinopril—dilated cardiomyopathy	0.00109	0.00123	CcSEcCtD
Tramadol—Angioedema—Lisinopril—dilated cardiomyopathy	0.00108	0.00121	CcSEcCtD
Tramadol—Malaise—Lisinopril—dilated cardiomyopathy	0.00107	0.0012	CcSEcCtD
Tramadol—Vertigo—Lisinopril—dilated cardiomyopathy	0.00106	0.00119	CcSEcCtD
Tramadol—Syncope—Lisinopril—dilated cardiomyopathy	0.00106	0.00119	CcSEcCtD
Tramadol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00106	0.00119	CcSEcCtD
Tramadol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00105	0.00118	CcSEcCtD
Tramadol—Palpitations—Lisinopril—dilated cardiomyopathy	0.00105	0.00117	CcSEcCtD
Tramadol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00104	0.00117	CcSEcCtD
Tramadol—Cough—Lisinopril—dilated cardiomyopathy	0.00103	0.00116	CcSEcCtD
Tramadol—Urticaria—Furosemide—dilated cardiomyopathy	0.00102	0.00115	CcSEcCtD
Tramadol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00102	0.00114	CcSEcCtD
Tramadol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00102	0.00114	CcSEcCtD
Tramadol—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00101	0.00113	CcSEcCtD
Tramadol—Chest pain—Lisinopril—dilated cardiomyopathy	0.00101	0.00113	CcSEcCtD
Tramadol—Myalgia—Lisinopril—dilated cardiomyopathy	0.00101	0.00113	CcSEcCtD
Tramadol—Anxiety—Lisinopril—dilated cardiomyopathy	0.001	0.00113	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.001	0.00112	CcSEcCtD
Tramadol—Discomfort—Lisinopril—dilated cardiomyopathy	0.000996	0.00112	CcSEcCtD
Tramadol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000986	0.00111	CcSEcCtD
Tramadol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000974	0.00109	CcSEcCtD
Tramadol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000966	0.00108	CcSEcCtD
Tramadol—Infection—Lisinopril—dilated cardiomyopathy	0.00096	0.00108	CcSEcCtD
Tramadol—Shock—Lisinopril—dilated cardiomyopathy	0.000951	0.00107	CcSEcCtD
Tramadol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000949	0.00106	CcSEcCtD
Tramadol—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000946	0.00106	CcSEcCtD
Tramadol—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000943	0.00106	CcSEcCtD
Tramadol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000938	0.00105	CcSEcCtD
Tramadol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000934	0.00105	CcSEcCtD
Tramadol—Asthenia—Furosemide—dilated cardiomyopathy	0.000924	0.00104	CcSEcCtD
Tramadol—Anorexia—Lisinopril—dilated cardiomyopathy	0.000921	0.00103	CcSEcCtD
Tramadol—Pruritus—Furosemide—dilated cardiomyopathy	0.000911	0.00102	CcSEcCtD
Tramadol—Hypotension—Lisinopril—dilated cardiomyopathy	0.000903	0.00101	CcSEcCtD
Tramadol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000881	0.000988	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00088	0.000987	CcSEcCtD
Tramadol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000874	0.00098	CcSEcCtD
Tramadol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000868	0.000973	CcSEcCtD
Tramadol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000861	0.000966	CcSEcCtD
Tramadol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000859	0.000963	CcSEcCtD
Tramadol—Dizziness—Furosemide—dilated cardiomyopathy	0.000852	0.000955	CcSEcCtD
Tramadol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00085	0.000954	CcSEcCtD
Tramadol—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00084	0.000942	CcSEcCtD
Tramadol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000834	0.000936	CcSEcCtD
Tramadol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000833	0.000934	CcSEcCtD
Tramadol—Pain—Lisinopril—dilated cardiomyopathy	0.000826	0.000927	CcSEcCtD
Tramadol—Constipation—Lisinopril—dilated cardiomyopathy	0.000826	0.000927	CcSEcCtD
Tramadol—Vomiting—Furosemide—dilated cardiomyopathy	0.000819	0.000918	CcSEcCtD
Tramadol—Rash—Furosemide—dilated cardiomyopathy	0.000812	0.000911	CcSEcCtD
Tramadol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000811	0.00091	CcSEcCtD
Tramadol—Headache—Furosemide—dilated cardiomyopathy	0.000807	0.000905	CcSEcCtD
Tramadol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000796	0.000893	CcSEcCtD
Tramadol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00079	0.000886	CcSEcCtD
Tramadol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000768	0.000861	CcSEcCtD
Tramadol—Nausea—Furosemide—dilated cardiomyopathy	0.000765	0.000858	CcSEcCtD
Tramadol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000764	0.000857	CcSEcCtD
Tramadol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000764	0.000857	CcSEcCtD
Tramadol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000712	0.000798	CcSEcCtD
Tramadol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000693	0.000778	CcSEcCtD
Tramadol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000684	0.000767	CcSEcCtD
Tramadol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000661	0.000742	CcSEcCtD
Tramadol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000639	0.000717	CcSEcCtD
Tramadol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000614	0.000689	CcSEcCtD
Tramadol—Rash—Lisinopril—dilated cardiomyopathy	0.000609	0.000683	CcSEcCtD
Tramadol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000609	0.000683	CcSEcCtD
Tramadol—Headache—Lisinopril—dilated cardiomyopathy	0.000605	0.000679	CcSEcCtD
Tramadol—Nausea—Lisinopril—dilated cardiomyopathy	0.000574	0.000644	CcSEcCtD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000308	0.00284	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000299	0.00275	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000299	0.00275	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000297	0.00274	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000297	0.00274	CbGpPWpGaD
Tramadol—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000297	0.00274	CbGpPWpGaD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000295	0.00271	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00029	0.00267	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000281	0.00259	CbGpPWpGaD
Tramadol—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000279	0.00257	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000279	0.00257	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000278	0.00256	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000276	0.00255	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000273	0.00252	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000269	0.00248	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000267	0.00247	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000267	0.00246	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000266	0.00245	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000266	0.00245	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000263	0.00243	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000263	0.00243	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000262	0.00242	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000259	0.00239	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000256	0.00236	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000256	0.00236	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000253	0.00233	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000253	0.00233	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000252	0.00233	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000245	0.00226	CbGpPWpGaD
Tramadol—HTR2C—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000243	0.00224	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00024	0.00221	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000238	0.00219	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000237	0.00219	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000235	0.00217	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00023	0.00212	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00023	0.00212	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000228	0.00211	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000227	0.0021	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000226	0.00209	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000226	0.00209	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000221	0.00204	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000218	0.00201	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000217	0.002	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000217	0.002	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00021	0.00194	CbGpPWpGaD
Tramadol—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000209	0.00193	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000204	0.00188	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000203	0.00187	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000201	0.00185	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000201	0.00185	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000197	0.00181	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000195	0.0018	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000195	0.0018	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000192	0.00177	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000192	0.00177	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000189	0.00174	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000187	0.00173	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000187	0.00172	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000187	0.00172	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000187	0.00172	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000183	0.00169	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000182	0.00168	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000182	0.00168	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000181	0.00167	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000181	0.00167	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.000177	0.00163	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000176	0.00162	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000176	0.00162	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000175	0.00162	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000174	0.0016	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000174	0.0016	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00017	0.00156	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000169	0.00155	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000165	0.00152	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000164	0.00151	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000164	0.00151	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000162	0.0015	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000161	0.00148	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.00016	0.00148	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00016	0.00147	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00016	0.00147	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000159	0.00146	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000154	0.00142	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.000153	0.00141	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000151	0.00139	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00015	0.00138	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000149	0.00137	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000149	0.00137	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000149	0.00137	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000147	0.00135	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000144	0.00133	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000143	0.00131	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000142	0.00131	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00014	0.00129	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000138	0.00128	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000138	0.00128	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000138	0.00127	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000135	0.00125	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000135	0.00125	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000135	0.00125	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000134	0.00124	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000133	0.00123	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00013	0.0012	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000129	0.00118	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000128	0.00118	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000128	0.00118	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000126	0.00116	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000123	0.00113	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000122	0.00113	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000122	0.00112	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000121	0.00112	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000119	0.0011	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000119	0.0011	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000117	0.00108	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000116	0.00107	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000116	0.00107	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000115	0.00106	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000114	0.00106	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000114	0.00105	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000113	0.00104	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00011	0.00101	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00011	0.00101	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000109	0.001	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000109	0.001	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000108	0.000995	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000108	0.000993	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000108	0.000993	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000106	0.000981	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000106	0.000978	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000105	0.000971	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000105	0.000963	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000104	0.000958	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000103	0.000952	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000103	0.000952	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000102	0.000943	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.0001	0.000923	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.0001	0.000921	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.0001	0.000921	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.98e-05	0.00092	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.91e-05	0.000913	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	9.87e-05	0.00091	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.86e-05	0.000909	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.83e-05	0.000906	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.7e-05	0.000894	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	9.59e-05	0.000884	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.53e-05	0.000879	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.45e-05	0.000871	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.45e-05	0.000871	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.33e-05	0.00086	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.29e-05	0.000856	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.06e-05	0.000835	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9e-05	0.000829	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.99e-05	0.000829	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.93e-05	0.000823	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	8.9e-05	0.00082	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.79e-05	0.00081	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	8.66e-05	0.000798	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.51e-05	0.000784	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.47e-05	0.000781	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.46e-05	0.00078	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.43e-05	0.000777	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.29e-05	0.000764	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.16e-05	0.000752	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.06e-05	0.000742	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.03e-05	0.00074	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.99e-05	0.000736	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.99e-05	0.000736	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.86e-05	0.000725	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.72e-05	0.000712	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.69e-05	0.000708	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.66e-05	0.000706	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.42e-05	0.000684	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	7.38e-05	0.00068	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	7.32e-05	0.000674	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.29e-05	0.000672	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.27e-05	0.00067	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.24e-05	0.000667	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.19e-05	0.000663	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.93e-05	0.000639	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.92e-05	0.000638	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.89e-05	0.000635	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.86e-05	0.000632	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.86e-05	0.000632	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.85e-05	0.000631	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.76e-05	0.000623	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.65e-05	0.000613	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.57e-05	0.000606	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.38e-05	0.000588	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	6.28e-05	0.000579	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	6.27e-05	0.000578	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.23e-05	0.000575	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.17e-05	0.000569	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.14e-05	0.000566	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.1e-05	0.000563	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.01e-05	0.000554	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.96e-05	0.000549	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.92e-05	0.000546	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.9e-05	0.000544	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.9e-05	0.000544	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	5.83e-05	0.000537	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.83e-05	0.000537	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.66e-05	0.000522	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.49e-05	0.000506	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	5.41e-05	0.000499	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.35e-05	0.000493	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.32e-05	0.00049	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.27e-05	0.000486	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	5.11e-05	0.000471	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.08e-05	0.000468	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.01e-05	0.000461	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	5e-05	0.000461	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.7e-05	0.000433	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.54e-05	0.000418	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.52e-05	0.000417	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.36e-05	0.000402	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	4.36e-05	0.000402	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	4.32e-05	0.000398	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.31e-05	0.000397	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.3e-05	0.000396	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CD36—dilated cardiomyopathy	4.24e-05	0.000391	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.12e-05	0.00038	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.05e-05	0.000373	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	3.88e-05	0.000358	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AGT—dilated cardiomyopathy	3.82e-05	0.000352	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.75e-05	0.000346	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	3.75e-05	0.000346	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	3.71e-05	0.000342	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.7e-05	0.000341	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	3.65e-05	0.000337	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.55e-05	0.000327	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.48e-05	0.000321	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	3.34e-05	0.000308	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	3.29e-05	0.000303	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	3.2e-05	0.000294	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	3e-05	0.000276	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.99e-05	0.000276	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.78e-05	0.000256	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.61e-05	0.00024	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.58e-05	0.000237	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.57e-05	0.000237	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.54e-05	0.000234	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.43e-05	0.000224	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.28e-05	0.000211	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.22e-05	0.000204	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.06e-05	0.00019	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.77e-05	0.000163	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.7e-05	0.000157	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.66e-05	0.000153	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.52e-05	0.00014	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.49e-05	0.000138	CbGpPWpGaD
